NCT06851143View on ClinicalTrials.gov

18F-DPA-714 PET/MR in Dysfunctional Brain Diseases

NANot yet recruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Brain Disease
Interventions
DIAGNOSTIC_TEST

18F-DPA-714 PET/MR scan

Saline intravenous solution of 18F-DPA-714 administered at 0.1 mCi/kg by bodyweight

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT06851143 - 18F-DPA-714 PET/MR in Dysfunctional Brain Diseases | Biotech Hunter | Biotech Hunter